ArticleInternational journal of hematology2021

Risk stratification model based on VEGF and International Prognostic Index accurately identifies low-risk diffuse large B-cell lymphoma patients in the rituximab era.

Wei Sang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.